The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia.
Chapiro
E
E
Radford-Weiss
I
I
Bastard
C
C
Luquet
I
I
Lefebvre
C
C
Callet-Bauchu
E
E
Leroux
D
D
Talmant
P
P
Mozziconacci
M-J
MJ
Mugneret
F
F
Struski
S
S
Raynaud
S
S
Andrieux
J
J
Barin
C
C
Jotterand
M
M
Mossafa
H
H
Ramond
S
S
Terré
C
C
Lippert
E
E
Berger
F
F
Felman
P
P
Merle-Béral
H
H
Bernard
O A
OA
Davi
F
F
Berger
R
R
Nguyen-Khac
F
F
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000081242:B-Cell Lymphoma 3 Protein; D002883:Chromosomes, Human, Pair 14 / Q000235:genetics*; D002888:Chromosomes, Human, Pair 19 / Q000235:genetics*; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D015448:Leukemia, B-Cell / Q000145:classification / Q000235:genetics* / Q000473:pathology; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000145:classification / Q000235:genetics* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016328:NF-kappa B / Q000235:genetics / Q000378:metabolism; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000378:metabolism; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism; D014178:Translocation, Genetic / Q000235:genetics*
D000081242:B-Cell Lymphoma 3 Protein; C000631344:BCL3 protein, human; D016328:NF-kappa B; D011518:Proto-Oncogene Proteins; D014157:Transcription Factors